Formulating Bone Health Products for a Broader Population of Consumers

For years, the bone health category has endured a reputation of being stagnant, dominated by calcium and basic vitamin D options. However, as the industry pivots toward a comprehensive longevity and active lifestyle paradigm, a transformation is underway. Driven by clinical data and consumer awareness, modern formulations are moving beyond simple mineral replenishment to address structural matrices, cellular mechanisms, and physiological synergies.

Based on research and innovations in this category, the marketplace is divided into 3 primary strategic areas: nutrient synergies, biological mechanisms, and cross-demographic market opportunities.

Why Are Nutrient Synergies Important?

Building modern bone health formulation requires an understanding of nutrient cofactors and material stability. Additionally, bone health nutrition is being seen as more complex than single vitamins or minerals working alone. For example, as Gene Bruno, DMB, MS, MHS, RH(AHG), chief scientific officer of Nutraland USA, highlighted at The Outlook on Women’s Wellness conference, “Vitamin D in bone health is super well established. It enhances calcium absorption and is essential for proper bone mineralization. Supplementation from vitamin D alone is generally insufficient to impact bone mineral density by itself. You need other things with it.”¹

The interaction between foundational vitamins and minerals can create a synergistic support system.²

• The Absorption and Activation Cascade
  • Vitamin D₃ facilitates the absorption of calcium and the synthesis of essential calcium-binding proteins.²
  • Vitamin K₂ (specifically menaquinone-7, or MK-7) activates these proteins, such as osteocalcin and matrix Gla protein. This vitamin regulates calcium in the body and inhibits calcification while playing an essential role in developing a strong bone matrix.^2,3
  • Magnesium unlocks the full biological potential of vitamin D₃.³

One example of a combination of these nutrients for targeting multiple areas is the Vital Trio concept from Balchem, a 3-in-1 formula of vitamin D₃, vitamin K₂ MK-7, and magnesium for immune, cardiovascular, and bone health support.⁴ This combination of benefits aligns with shifting consumer values of multi-benefit support. “Consumer research data relating to our Vital Trio concept reflects strong interest in heart, immune, and bone health solutions across North America and three key European markets,” confirms Thies Ripcke, Director Business Development and Strategic Marketing for K2VITAL, Balchem Human Nutrition and Health.

Beyond structural and foundational nutrients, formulators must balance elemental density against bioavailability and ensure stability of the nutrients.

• The Formulation Dilemma (Oxide vs Chelates): Magnesium oxide offers high elemental magnesium content and, as Bruno notes, is the only magnesium salt to demonstrate support for bone mass accrual in a randomized controlled trial.^1,4 However, it also exhibit poor baseline absorption.⁴ Magnesium citrate is noted for its bioavailability, though as Ripcke highlights, the chelated mineral magnesium glycinate has demonstrated improved absorption compared with magnesium oxide or magnesium citrate. It is also noted for its tolerability, and efficacy can pair well with vitamin K₂ and zinc, for example.⁴ Additional challenges with magnesium formulation are metallic taste, mouthfeel, and pH balance.
• The Ingredient Degradation Challenge: One aspect to note is the instability of unprotected vitamin K₂.³ When combined with moisture and mineral salts, standard vitamin K₂ can degrade rapidly, frequently causing a reduction of vitamin content. “The key to avoiding these ‘awkward interactions’ starts early in development with testing nutrient compatibility and applying protective technologies such as microencapsulation to sensitive ingredients so that potency holds through manufacturing and storage,” Ripcke explains.

What Do Biological Mechanisms and Advanced Ingredients Show?

Bone health innovation is also targeting cellular signaling and hormonal pathways directly. Milk basic protein and bioactive collagen peptides support bone remodeling at the cellular level, while S-equol offers postmenopausal women a targeted alternative to standard isoflavones. Emerging research into the gut-bone axis further reveals how microbial metabolites influence osteoblast activity.

• Milk Protein and Peptides
  • Milk Basic Protein (MBP): Bruno highlights MBP as a bone-building compound, which is a bioactive whey fraction rich in lactoferrin and lactoperoxidase.¹ It is noted for a uniquely rapid mechanism of action: actively promoting osteoblast proliferation and differentiation while suppressing excessive osteoclast activity.¹ In double-blind, placebo-controlled trials, a dose of 40 mg/day significantly increased bone mineral density (BMD) across multiple age strata within a 6-month timeframe.⁵
  • Bioactive Collagen Peptides: Functioning as flexible scaffolding mineral depositions, collagen makes up anywhere from 30% to 90% of bone organic matrix, Bruno notes.¹ A longitudinal clinical trial with 131 postmenopausal women showed that a daily dose of 5 g significantly improves femoral neck and spine BMD over 12 months, with follow-up data showing continued bone mass accrual over 4 years, highlighting the long-term effects of supplementation.^6,7
• Hormonal Signaling Pathways
  • S-Equol: Fulfilling a critical niche in postmenopausal health, the selective estrogen receptor β modulator S-equol bypasses a major metabolic limitation.¹ While soy isoflavones have long been investigated for bone support, Bruno highlights that only 25% to 35% of women naturally possess the gut microbiota necessary to convert dietary daidzein into equol.¹ Research indicates that direct supplementation with 10 mg/day of S-equol (especially when paired with polyphenols like resveratrol) in postmenopausal cohorts improves bone turnover markers with whole-body BMD maintained.⁸
• The Gut-Bone Axis
  • Microbial Metabolites: One area in skeletal longevity is the relationship between the gut microbiome and bone remodeling.⁹ For example, the microbiome is a source of vitamin K₂, which stimulates osteoblasts required for bone formation and osteocalcin function. The microbiome can also affect bone remodeling by interacting with T cells as well as hormones.¹⁰

What Are the Cross-Demographic Market Opportunities?

Formulators are shifting away from general, one-size-fits-all products toward targeted demographic solutions that leverage distinct physiological needs. As awareness of bone density spreads beyond older adults, brands have room to also reach perimenopausal women and younger health-conscious consumers alike. Cross-demographic appeal means formulators can differentiate through dosing, delivery format, and ingredient pairing suited to each group's specific needs.

Ripcke notes how brands can further stand out in this category. “For men, women, or anyone focused on long-term mobility, tying bone density, heart health, and immunity support into one formulation offers a practical advantage over single-nutrient products, and a clear point of differentiation for brands.”

The Next Chapter in Bone Health

Bone health is evolving from a single-nutrient support into a broader wellness priority spanning age groups and genders. Ingredients like milk basic protein, bioactive collagen peptides, and vitamin K₂ are redefining what "bone health" means to formulators and consumers alike. “Over the next three to five years, bone health will likely move from a narrow post-menopause focus into a broader healthy aging category,” Ripcke states. “As the population ages, maintaining bone strength and mobility will matter for both men and women at any life stage.”

As mechanistic research is conducted on newer ingredients, brands have a clear opening to innovate beyond calcium and vitamin D.

References

1. Saraceno N. Why bone health formulation goes beyond calcium. Nutritional Outlook. June 11, 2026. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/why-bone-health-formulation-goes-beyond-calcium
2. Colli M. Building a lifelong foundation for bone health. Nutritional Outlook. October 16, 2025. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/building-a-lifelong-foundation-for-bone-health
3. Krawiec S. Spotlight on vitamin K2. Nutritional Outlook. March 14, 2024. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/spotlight-on-vitamin-k2
4. Straus M. Understanding the magnesium market. Nutritional Outlook. September 17, 2025. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/understanding-the-magnesium-market
5. Aoe S, Toba Y, Yamamura JI, et al. Controlled trial of the effect of milk basic protein (MBP) supplementation on bone metabolism in healthy adult women. Biosci Biotechnol Biochem. 2001;65(4):913-918. doi:10.1271/bbb.65.913
6. König D, Oesser S, Scharla S, Zdzieblik D, Gollhofer A. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women-a randomized controlled study. Nutrients. 2018;10(1):97. doi:10.3390/nu10010097
7. Zdzieblik D, Oesser S, König D. Specific bioactive collagen peptides in osteopenia and osteoporosis: long-term observation in postmenopausal women. J Bone Metab. 2021;28(3):207–213. doi:10.11005/jbm.2021.28.3.207
8. Corbi G, Nobile V, Conti V, et al. Equol and resveratrol improve bone turnover biomarkers in postmenopausal women: a clinical trial. Int J Mol Sci. 2023;24(15):12063. doi:10.3390/ijms241512063
9. Krawiec S. Healthy bones via the gut. Nutritional Outlook. October 8, 2024. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/healthy-bones-via-the-gut
10. Lyu Z, Hu Y, Guo Y, Liu D. Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis. Bone Res. 2023;11(1):31. doi:10.1038/s41413-023-00264-x
11. Krawiec S. Bone health in men: important but neglected. Nutritional Outlook. April 30, 2026. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/bone-health-in-men-important-but-neglected
12. Rizzoli R, Chevalley T. Nutrition and osteoporosis prevention. Curr Osteoporos Rep 2024;22(6):515-522. doi:10.1007/s11914-024-00892-0
13. Reilly MK. Osteoporosis and aging: Essential nutrients for women. Nutritional Outlook. May 15, 2025. Accessed July 8, 2026. https://www.nutritionaloutlook.com/view/osteoporosis-and-aging-essential-nutrients-for-women